Sutent for sale in India Sutent price in India Sutent free drug price

WeChat consultation hotline. If the call cannot be reached, please add WeChat or the generic name of Sunitinib Malate Capsules. Our company promises to be honest and sell genuine products at real prices. Cash on delivery. Generic name: Sunitinib Malate Capsules. Molecular structure name: Sunitinib Malate. English name in English Specifications × capsules/box Usage: Take the capsules once a day. The drug needs to be stopped after one week of administration and observed for one week. Continue to take the treatment course for one week/treatment course. Indications: Advanced gastrointestinal stromal tumors that have failed or are intolerable to imatinib treatment. Pfizer, the manufacturer of renal cell carcinoma, has indications in addition to inhibiting gastrointestinal stromal tumors and advanced renal cell carcinoma. It is now clinically proven to treat non-small cell lung cancer and treat hepatocellular carcinoma. Sutent Indications: Gastrointestinal stromal tumors that have failed or are intolerable to imatinib mesylate. Inoperable, advanced renal cell carcinoma. Sunitinib - a new drug for renal cancer, gastrointestinal stromal tumor, non-small cell lung cancer and liver cancer. Indications Multi-targeted treatment of tumors Sunitinib is a new multi-targeted oral drug for the treatment of tumors. Sunitinib is primarily being developed for the treatment of gastrointestinal stromal tumors and metastatic renal cell carcinoma that are unresponsive or intolerant to standard therapies. Sunitinib selectively targets certain protein receptors, which are thought to act as a molecular switch in tumor growth. The above indications for sunitinib/> Dosage and Administration of Sunitin The recommended dose for the treatment of gastrointestinal stromal tumors and advanced renal cell carcinoma is oral administration once daily for 12 weeks with 1 week off. It can be taken with or without food. Sutent Precautions It is recommended to discontinue the drug if clinical manifestations of congestive heart failure occur. Patients with no clinical evidence of congestive heart failure but ejection fractions and ejection fractions below baseline should also be discontinued and/or dose reduced. Sutent prolongs the interval in a dose-dependent manner. It should be used with caution in patients with a known history of interval prolongation, patients taking antiarrhythmic drugs, or patients with underlying cardiac disease bradycardia and electrolyte imbalance. If severe hypertension occurs during use, use should be suspended until the hypertension is controlled. Women of childbearing potential should use contraception while receiving Sutent. Breastfeeding women receiving Sutent should weigh their decision as to whether to discontinue breastfeeding or discontinue treatment. No differences in safety or effectiveness were found in younger versus older patients. The contents of Sutent capsules are ** to orange granules. Sutent Validity Period Months Sutent Approval Number Registration Certificate Number Sutent Manufacturer